Warning: The NCBI web site requires JavaScript to function. more...
1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice.
Su Y, Vanderlaag K, Ireland C, Ortiz J, Grage H, Safe S, Frankel AE.
Breast Cancer Res. 2007;9(4):R56.
Related citations
1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through PPARgamma-dependent and PPARgamma-independent pathways.
Chintharlapalli S, Papineni S, Safe S.
Mol Cancer Ther. 2006 May;5(5):1362-70.
1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
Vanderlaag K, Su Y, Frankel AE, Grage H, Smith R 3rd, Khan S, Safe S.
Breast Cancer Res Treat. 2008 May;109(2):273-83. Epub 2007 Jul 12.
Inhibition of bladder tumor growth by 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes: a new class of peroxisome proliferator-activated receptor gamma agonists.
Kassouf W, Chintharlapalli S, Abdelrahim M, Nelkin G, Safe S, Kamat AM.
Cancer Res. 2006 Jan 1;66(1):412-8.
Anti-tumor potential of 15,16-dihydrotanshinone I against breast adenocarcinoma through inducing G1 arrest and apoptosis.
Tsai SL, Suk FM, Wang CI, Liu DZ, Hou WC, Lin PJ, Hung LF, Liang YC.
Biochem Pharmacol. 2007 Dec 3;74(11):1575-86. Epub 2007 Aug 11.
In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models.
Hoeflich KP, O'Brien C, Boyd Z, Cavet G, Guerrero S, Jung K, Januario T, Savage H, Punnoose E, Truong T, Zhou W, Berry L, Murray L, Amler L, Belvin M, Friedman LS, Lackner MR.
Clin Cancer Res. 2009 Jul 15;15(14):4649-64. Epub 2009 Jun 30.
Metformin induces unique biological and molecular responses in triple negative breast cancer cells.
Liu B, Fan Z, Edgerton SM, Deng XS, Alimova IN, Lind SE, Thor AD.
Cell Cycle. 2009 Jul 1;8(13):2031-40. Epub 2009 Jul 21.
Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
Coxon A, Bush T, Saffran D, Kaufman S, Belmontes B, Rex K, Hughes P, Caenepeel S, Rottman JB, Tasker A, Patel V, Kendall R, Radinsky R, Polverino A.
Clin Cancer Res. 2009 Jan 1;15(1):110-8.
Antrodia camphorata inhibits proliferation of human breast cancer cells in vitro and in vivo.
Hseu YC, Chen SC, Chen HC, Liao JW, Yang HL.
Food Chem Toxicol. 2008 Aug;46(8):2680-8. Epub 2008 May 4.
Novel antitumor effect of estradiol in athymic mice injected with a T47D breast cancer cell line overexpressing protein kinase Calpha.
Chisamore MJ, Ahmed Y, Bentrem DJ, Jordan VC, Tonetti DA.
Clin Cancer Res. 2001 Oct;7(10):3156-65.
Antitumor activity of edotecarin in breast carcinoma models.
Ciomei M, Croci V, Stellari F, Amboldi N, Giavarini R, Pesenti E.
Cancer Chemother Pharmacol. 2007 Jul;60(2):229-35. Epub 2006 Nov 7.
1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce apoptosis and inhibit renal cell carcinoma growth.
York M, Abdelrahim M, Chintharlapalli S, Lucero SD, Safe S.
Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6743-52.
Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
Yu J, Qiao L, Zimmermann L, Ebert MP, Zhang H, Lin W, Röcken C, Malfertheiner P, Farrell GC.
Hepatology. 2006 Jan;43(1):134-43.
[Ciglitazone inhibits growth of lung cancer cells A549 in vitro and in vivo: an experimental study].
Zhang HL, Zhang ZX, Xu YJ.
Zhonghua Zhong Liu Za Zhi. 2004 Sep;26(9):531-4. Chinese.
Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
Magenta G, Borenstein X, Rolando R, Jasnis MA.
BMC Cancer. 2008 Feb 8;8:47.
Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.
Shankar S, Davis R, Singh KP, Kurzrock R, Ross DD, Srivastava RK.
Mol Cancer Ther. 2009 Jun;8(6):1596-605. Epub 2009 Jun 9.
1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes are peroxisome proliferator-activated receptor gamma agonists but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response-1 and nonsteroidal anti-inflammatory drug-activated gene-1.
Chintharlapalli S, Papineni S, Baek SJ, Liu S, Safe S.
Mol Pharmacol. 2005 Dec;68(6):1782-92. Epub 2005 Sep 9.
Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
Chen P, Cameron R, Wang J, Vallis KA, Reilly RM.
J Nucl Med. 2003 Sep;44(9):1469-78.
In vitro and in vivo antitumorigenic activity of a mixture of lysine, proline, ascorbic acid, and green tea extract on human breast cancer lines MDA-MB-231 and MCF-7.
Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M.
Med Oncol. 2005;22(2):129-38.
1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes inhibit growth, induce apoptosis, and decrease the androgen receptor in LNCaP prostate cancer cells through peroxisome proliferator-activated receptor gamma-independent pathways.
Mol Pharmacol. 2007 Feb;71(2):558-69. Epub 2006 Nov 8.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on